»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¿ä¼Òȸ·ÎÀÌ»óÁõ Ä¡·á ½ÃÀåÀº 2024-2029³â 2¾ï 2,740¸¸ ´Þ·¯ Áõ°¡Çϰí, ¿¹Ãø ±â°£ µ¿¾È 3.3%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¼¼°èÀÇ ¿ä¼Òȸ·ÎÀÌ»óÁõ Ä¡·á ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ ´ë»óÀ¸·Î ÇÑ º¥´õ ºÐ¼® µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
ÇöÀçÀÇ ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ ¹× ¼ºÀå¿äÀÎ, Àüü ½ÃÀå ȯ°æ¿¡ ´ëÇÑ ÃֽŠºÐ¼®À» Á¦°øÇÕ´Ï´Ù. ÀÌ ½ÃÀåÀº ¿ä¼ÒÁÖ±â ÀÌ»óÁõÀÇ À¯º´·ü Áõ°¡, ³ëÀΠȯÀÚ Áõ°¡, Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê¿¡ ´ëÇÑ °ü½É Áõ°¡¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.
½ÃÀå ¹üÀ§
±âÁØ ¿¬µµ
2025³â
Á¾·á ¿¬µµ
2029³â
¿¹Ãø ±â°£
2025-2029³â
¼ºÀå ¸ð¸àÅÒ
°¡¼Ó
Àü³â ´ëºñ 2025³â
3.1%
CAGR
3.3%
Áõ°¡¾×
2¾ï 2,740¸¸ ´Þ·¯
ÀÌ Á¶»ç´Â ¾÷°è ÁÖ¿ä Âü°¡ÀÚÀÇ ÀǰßÀ» Æ÷ÇÔÇÏ¿© 1Â÷ ¹× 2Â÷ Á¤º¸¸¦ °´°üÀûÀ¸·Î °áÇÕÇÏ¿© ¼öÇàµÇ¾ú½À´Ï´Ù. ÀÌ º¸°í¼¿¡´Â ÁÖ¿ä ±â¾÷ ºÐ¼®, Á¾ÇÕÀûÀÎ ½ÃÀå ±Ô¸ð µ¥ÀÌÅÍ, Áö¿ªº° ºÐ¼®¿¡ µû¸¥ ºÎ¹®, °ø±Þ¾÷ü ÇöȲÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. º¸°í¼¿¡´Â °ú°Å µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅͰ¡ ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼´Â ÇâÈÄ ¸î ³âµ¿¾È ¿ä¼Òȸ·ÎÀÌ»óÁõ Ä¡·á ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß Çϳª·Î ½ÅÈï±¹¿¡¼ÀÇ ¼ºÀå ÀáÀç·Â Áõ°¡¸¦ ²Å¾Ò½À´Ï´Ù. ¶ÇÇÑ, Á¶±â °ËÁø ¹× Áø´Ü¿¡ ´ëÇÑ ±â¼ú ¹ßÀü Áõ°¡¿Í ¿ä¼ÒÁÖ±â ÀÌ»óÁõ Ä¡·á¿¡ ÀÖ¾î µ¿¹Ý Áø´Ü¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå ¼ö¿ä°¡ Å©°Ô ´Ã¾î³¯ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå Technavio ºÐ¼®
°¡°Ý, ¼ö¸íÁÖ±â, °í°´ ±¸ÀÔ ¹Ù½ºÄÏ, äÅà ºñÀ², ±¸ÀÔ ±âÁØ ºÐ¼®
ÀÎDzÀÇ Á߿伺°ú Â÷º°È ¿äÀÎ
È¥¶õ ¿äÀÎ
¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
Á¦3Àå ½ÃÀå ±¸µµ
½ÃÀå »ýŰè
½ÃÀå Æ¯Â¡
¹ë·ùüÀÎ ºÐ¼®
Á¦4Àå ½ÃÀå ±Ô¸ð
½ÃÀåÀÇ Á¤ÀÇ
½ÃÀå ºÎ¹® ºÐ¼®
½ÃÀå ±Ô¸ð 2024
½ÃÀå Àü¸Á 2024-2029
Á¦5Àå ½ÃÀå ±Ô¸ð ½ÇÀû
¼¼°èÀÇ ¿ä¼Òȸ·ÎÀÌ»óÁõ Ä¡·á ½ÃÀå(2019-2023³â)
Ä¡·áº° ºÎ¹® ºÐ¼®(2019-2023³â)
Åõ¿© °æ·Îº° ºÎ¹® ºÐ¼®(2019-2023³â)
ÃÖÁ¾»ç¿ëÀÚº° ºÎ¹® ºÐ¼®(2019-2023³â)
Áö¿ªº° ºÎ¹® ºÐ¼®(2019-2023³â)
±¹°¡º° ºÎ¹® ºÐ¼®(2019-2023³â)
Á¦6Àå Á¤¼º ºÐ¼®
AIÀÇ ¿µÇâ : ¼¼°èÀÇ ¿ä¼Òȸ·ÎÀÌ»óÁõ Ä¡·á ½ÃÀå
Á¦7Àå Five Forces ºÐ¼®
Five Forces ¿ä¾à
¹ÙÀ̾îÀÇ ±³¼··Â
°ø±Þ ±â¾÷ÀÇ ±³¼··Â
½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
´ëüǰÀÇ À§Çù
°æÀï À§Çù
½ÃÀå ÇöȲ
Á¦8Àå ½ÃÀå ¼¼ºÐÈ ¼¼¶óÇÇ
½ÃÀå ºÎ¹®
ºñ±³ : Ä¡·áº°
±Û¸®¼¼·Ñ Æä´ÒºÎÆ¿·¹ÀÌÆ® : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
Æä´Ò ³«»ê ³ªÆ®·ý : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¾Æ¹Ì³ë»ê º¸ÃæÁ¦ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
º¥Á¶»ê ³ªÆ®·ý : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
±âŸ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ÃÀå ±âȸ ¼¼¶óÇÇ
Á¦9Àå ½ÃÀå ¼¼ºÐÈ : Åõ¿© °æ·Îº°
½ÃÀå ºÎ¹®
ºñ±³ : Åõ¿© °æ·Îº°
°æ±¸ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ÁÖ»çÁ¦ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ÃÀå ±âȸ : Åõ¿© °æ·Îº°
Á¦10Àå ½ÃÀå ¼¼ºÐÈ : ÃÖÁ¾»ç¿ëÀÚº°
½ÃÀå ºÎ¹®
ºñ±³ : ÃÖÁ¾»ç¿ëÀÚº°
º´¿ø : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
Àü¹® Ŭ¸®´Ð : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ȨÄɾî : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¿¬±¸±â°ü : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ÃÀå ±âȸ : ÃÖÁ¾»ç¿ëÀÚº°
Á¦11Àå °í°´ »óȲ
Á¦12Àå Áö¿ªº° »óȲ
Áö¿ªº° ¼¼ºÐÈ
Áö¿ªº° ºñ±³
ºÏ¹Ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
À¯·´ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¾Æ½Ã¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¼¼°è ±âŸ Áö¿ª : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¹Ì±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
µ¶ÀÏ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
Áß±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ij³ª´Ù : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ÀϺ» : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¿µ±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ÇÁ¶û½º : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
Àεµ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ÀÌÅ»¸®¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ºê¶óÁú : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ÃÀå ±âȸ : Áö¿ª »óȲº°
Á¦13Àå ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ±âȸ ¹× ¼ºÀå ¾ïÁ¦¿äÀÎ
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
½ÃÀå ±âȸ¿Í ¼ºÀå ¾ïÁ¦¿äÀÎ
Á¦14Àå °æÀï ±¸µµ
°³¿ä
°æÀï ±¸µµ
È¥¶õ »óȲ
¾÷°è ¸®½ºÅ©
Á¦15Àå °æÀï ºÐ¼®
±â¾÷ °³¿ä
±â¾÷ ¼øÀ§ Áö¼ö
±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×
Abbott Laboratories
Acer Therapeutics Inc.
Arcturus Therapeutics Holdings Inc.
Bausch Health Companies Inc.
Boehringer Ingelheim International GmbH
CAMP4
Eurocept B.V.
Horizon Therapeutics Plc
Medunik USA
Orpharma Pty Ltd.
Recordati S.p.A
RELIEF THERAPEUTICS Holding SA
Spyre Therapeutics Inc.
Synlogic Inc.
Ultragenyx Pharmaceutical Inc.
Á¦16Àå ºÎ·Ï
LSH
The urea cycle disorder treatment market is forecasted to grow by USD 227.4 million during 2024-2029, accelerating at a CAGR of 3.3% during the forecast period. The report on the urea cycle disorder treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of urea cycle disorder, rising geriatric patients, and rising focus on strategic initiatives.
Market Scope
Base Year 2025
End Year 2029
Series Year 2025-2029
Growth Momentum Accelerate
YOY 2025 3.1%
CAGR 3.3%
Incremental Value $227.4 mn
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's urea cycle disorder treatment market is segmented as below:
By Therapy
Glycerol phenylbutyrate
Sodium phenylbutyrate
Amino acid supplements
Sodium benzoate
Others
By Route Of Administration
By End-user
Hospitals
Specialized clinics
Home care settings
Research institutions
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)
This study identifies the increasing growth potential in emerging economies as one of the prime reasons driving the urea cycle disorder treatment market growth during the next few years. Also, increasing technological advancements in terms of early screening and diagnosis and growing need for companion diagnostics in treatment of UCD will lead to sizable demand in the market.
The report on the urea cycle disorder treatment market covers the following areas:
Urea Cycle Disorder Treatment Market sizing
Urea Cycle Disorder Treatment Market forecast
Urea Cycle Disorder Treatment Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading urea cycle disorder treatment market vendors that include Abbott Laboratories, Acer Therapeutics Inc., Arcturus Therapeutics Holdings Inc., Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, CAMP4, Dipharma SA, Eurocept B.V., Horizon Therapeutics PLC, Immedica Pharma AB, Medunik USA, Nestle SA, Orpharma Pty Ltd., Reckitt Benckiser Group PLC, Recordati S.p.A, RELIEF THERAPEUTICS Holding SA, Spyre Therapeutics Inc., Swedish Orphan Biovitrum AB, Synlogic Inc., and Ultragenyx Pharmaceutical Inc.. Also, the urea cycle disorder treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Therapy
Executive Summary - Chart on Market Segmentation by Route of Administration
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Urea Cycle Disorder Treatment Market 2019 - 2023
Historic Market Size - Data Table on Global Urea Cycle Disorder Treatment Market 2019 - 2023 ($ million)
5.2 Therapy segment analysis 2019 - 2023
Historic Market Size - Therapy Segment 2019 - 2023 ($ million)
5.3 Route of Administration segment analysis 2019 - 2023
Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
5.4 End-user segment analysis 2019 - 2023
Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on Global Urea Cycle Disorder Treatment Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Therapy
8.1 Market segments
Chart on Therapy - Market share 2024-2029 (%)
Data Table on Therapy - Market share 2024-2029 (%)
8.2 Comparison by Therapy
Chart on Comparison by Therapy
Data Table on Comparison by Therapy
8.3 Glycerol phenylbutyrate - Market size and forecast 2024-2029
Chart on Glycerol phenylbutyrate - Market size and forecast 2024-2029 ($ million)
Data Table on Glycerol phenylbutyrate - Market size and forecast 2024-2029 ($ million)
Chart on Glycerol phenylbutyrate - Year-over-year growth 2024-2029 (%)
Data Table on Glycerol phenylbutyrate - Year-over-year growth 2024-2029 (%)
8.4 Sodium phenylbutyrate - Market size and forecast 2024-2029
Chart on Sodium phenylbutyrate - Market size and forecast 2024-2029 ($ million)
Data Table on Sodium phenylbutyrate - Market size and forecast 2024-2029 ($ million)
Chart on Sodium phenylbutyrate - Year-over-year growth 2024-2029 (%)
Data Table on Sodium phenylbutyrate - Year-over-year growth 2024-2029 (%)
8.5 Amino acid supplements - Market size and forecast 2024-2029
Chart on Amino acid supplements - Market size and forecast 2024-2029 ($ million)
Data Table on Amino acid supplements - Market size and forecast 2024-2029 ($ million)
Chart on Amino acid supplements - Year-over-year growth 2024-2029 (%)
Data Table on Amino acid supplements - Year-over-year growth 2024-2029 (%)
8.6 Sodium benzoate - Market size and forecast 2024-2029
Chart on Sodium benzoate - Market size and forecast 2024-2029 ($ million)
Data Table on Sodium benzoate - Market size and forecast 2024-2029 ($ million)
Chart on Sodium benzoate - Year-over-year growth 2024-2029 (%)
Data Table on Sodium benzoate - Year-over-year growth 2024-2029 (%)
8.7 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
8.8 Market opportunity by Therapy
Market opportunity by Therapy ($ million)
Data Table on Market opportunity by Therapy ($ million)
9 Market Segmentation by Route of Administration
9.1 Market segments
Chart on Route of Administration - Market share 2024-2029 (%)
Data Table on Route of Administration - Market share 2024-2029 (%)
9.2 Comparison by Route of Administration
Chart on Comparison by Route of Administration
Data Table on Comparison by Route of Administration
9.3 Oral - Market size and forecast 2024-2029
Chart on Oral - Market size and forecast 2024-2029 ($ million)
Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Chart on Oral - Year-over-year growth 2024-2029 (%)
Data Table on Oral - Year-over-year growth 2024-2029 (%)
9.4 Injectables - Market size and forecast 2024-2029
Chart on Injectables - Market size and forecast 2024-2029 ($ million)
Data Table on Injectables - Market size and forecast 2024-2029 ($ million)
Chart on Injectables - Year-over-year growth 2024-2029 (%)
Data Table on Injectables - Year-over-year growth 2024-2029 (%)
9.5 Market opportunity by Route of Administration
Market opportunity by Route of Administration ($ million)
Data Table on Market opportunity by Route of Administration ($ million)
10 Market Segmentation by End-user
10.1 Market segments
Chart on End-user - Market share 2024-2029 (%)
Data Table on End-user - Market share 2024-2029 (%)
10.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
10.3 Hospitals - Market size and forecast 2024-2029
Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
Chart on Hospitals - Year-over-year growth 2024-2029 (%)
Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
10.4 Specialized clinics - Market size and forecast 2024-2029
Chart on Specialized clinics - Market size and forecast 2024-2029 ($ million)
Data Table on Specialized clinics - Market size and forecast 2024-2029 ($ million)
Chart on Specialized clinics - Year-over-year growth 2024-2029 (%)
Data Table on Specialized clinics - Year-over-year growth 2024-2029 (%)
10.5 Home care settings - Market size and forecast 2024-2029
Chart on Home care settings - Market size and forecast 2024-2029 ($ million)
Data Table on Home care settings - Market size and forecast 2024-2029 ($ million)
Chart on Home care settings - Year-over-year growth 2024-2029 (%)
Data Table on Home care settings - Year-over-year growth 2024-2029 (%)
10.6 Research institutions - Market size and forecast 2024-2029
Chart on Research institutions - Market size and forecast 2024-2029 ($ million)
Data Table on Research institutions - Market size and forecast 2024-2029 ($ million)
Chart on Research institutions - Year-over-year growth 2024-2029 (%)
Data Table on Research institutions - Year-over-year growth 2024-2029 (%)
10.7 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)
11 Customer Landscape
11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.9 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
12.10 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.11 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.12 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
12.13 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
12.14 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
12.15 Italy - Market size and forecast 2024-2029
Chart on Italy - Market size and forecast 2024-2029 ($ million)
Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Chart on Italy - Year-over-year growth 2024-2029 (%)
Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.16 Brazil - Market size and forecast 2024-2029
Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Chart on Brazil - Year-over-year growth 2024-2029 (%)
Data Table on Brazil - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
15.2 Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
15.4 Abbott Laboratories
Abbott Laboratories - Overview
Abbott Laboratories - Business segments
Abbott Laboratories - Key news
Abbott Laboratories - Key offerings
Abbott Laboratories - Segment focus
SWOT
15.5 Acer Therapeutics Inc.
Acer Therapeutics Inc. - Overview
Acer Therapeutics Inc. - Product / Service
Acer Therapeutics Inc. - Key offerings
SWOT
15.6 Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc. - Overview
Arcturus Therapeutics Holdings Inc. - Product / Service
Arcturus Therapeutics Holdings Inc. - Key offerings
SWOT
15.7 Bausch Health Companies Inc.
Bausch Health Companies Inc. - Overview
Bausch Health Companies Inc. - Business segments
Bausch Health Companies Inc. - Key news
Bausch Health Companies Inc. - Key offerings
Bausch Health Companies Inc. - Segment focus
SWOT
15.8 Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH - Overview
Boehringer Ingelheim International GmbH - Product / Service
Boehringer Ingelheim International GmbH - Key news
Boehringer Ingelheim International GmbH - Key offerings
SWOT
15.9 CAMP4
CAMP4 - Overview
CAMP4 - Product / Service
CAMP4 - Key offerings
SWOT
15.10 Eurocept B.V.
Eurocept B.V. - Overview
Eurocept B.V. - Product / Service
Eurocept B.V. - Key offerings
SWOT
15.11 Horizon Therapeutics Plc
Horizon Therapeutics Plc - Overview
Horizon Therapeutics Plc - Product / Service
Horizon Therapeutics Plc - Key offerings
SWOT
15.12 Medunik USA
Medunik USA - Overview
Medunik USA - Product / Service
Medunik USA - Key offerings
SWOT
15.13 Orpharma Pty Ltd.
Orpharma Pty Ltd. - Overview
Orpharma Pty Ltd. - Product / Service
Orpharma Pty Ltd. - Key offerings
SWOT
15.14 Recordati S.p.A
Recordati S.p.A - Overview
Recordati S.p.A - Business segments
Recordati S.p.A - Key offerings
Recordati S.p.A - Segment focus
SWOT
15.15 RELIEF THERAPEUTICS Holding SA
RELIEF THERAPEUTICS Holding SA - Overview
RELIEF THERAPEUTICS Holding SA - Product / Service
RELIEF THERAPEUTICS Holding SA - Key offerings
SWOT
15.16 Spyre Therapeutics Inc.
Spyre Therapeutics Inc. - Overview
Spyre Therapeutics Inc. - Product / Service
Spyre Therapeutics Inc. - Key offerings
SWOT
15.17 Synlogic Inc.
Synlogic Inc. - Overview
Synlogic Inc. - Product / Service
Synlogic Inc. - Key offerings
SWOT
15.18 Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc. - Overview
Ultragenyx Pharmaceutical Inc. - Product / Service
Ultragenyx Pharmaceutical Inc. - Key offerings
SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
16.5 Data procurement
16.6 Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations